These O6MeG-dependent replication blocking lesions activate the DNA damage response (DDR) kinases ATM and ATR [18], thereby initiating bypass in glioma cells in a tolerance mechanism that requires homologous recombination (HR) [19, 20]. The gene discussed is ATM; the disease is central nervous system cancer.